Stocks and Investing Stocks and Investing
Tue, April 27, 2021
Mon, April 26, 2021

Andrew Berens Initiated (VIRX) at Buy and Held Target at $18 on, Apr 26th, 2021


Published on 2024-10-27 16:22:39 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Initiated "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $18 on, Apr 26th, 2021.

Andrew has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $45 on, Thursday, March 25th, 2021
Contributing Sources